David Einhorn - Greenlight Capital
Holding/activity history for Talis Biomedical Corp. (TLIS)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2024 Q3 | 0 | 0 | Sell 100.00% | 0.06 | |
| 2024 Q2 | 149,052 | 0.06 | $8.66 | ||
| 2024 Q1 | 149,052 | 0.06 | $8.75 | ||
| 2023 Q4 | 149,052 | 0.05 | $7.45 | ||
| 2023 Q3 | 149,052 | 0.05 | Add 0.00% | 0.00 | $5.77 |
| 2023 Q2 | 149,051 | 0.05 | Reduce 0.00% | 0.00 | $7.20 |
| 2023 Q1 | 149,052 | 0.06 | $7.35 | ||
| 2022 Q4 | 149,052 | 0.07 | $6.69 | ||
| 2022 Q3 | 149,052 | 0.11 | $10.22 | ||
| 2022 Q2 | 149,052 | 0.14 | $12.18 | ||
| 2022 Q1 | 149,052 | 0.20 | Add 42.47% | 0.06 | $21.15 |
| 2021 Q4 | 104,620 | 0.38 | Buy | 0.38 | $60.15 |